CSI Market
Sign In | Register

Bright Minds Biosciences Inc (DRUG) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DRUG Annual Balance Sheets →
From Bright Minds Biosciences Inc through Sep 30 2024, shifts in Sep 30 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
0 0 0 (Sep 30 2024)
Assets
Cash And Cash Equivalents63.51
Current Tax Assets Current0.16
Cash & Short-term Investments63.00
Other Current Assets0.91
Total Current Assets64.58
Other Assets, Noncurrent0.09
Total Assets64.67
Liabilities
Other Liabilities, Current1.79
Total Current Liabilities1.79
Total Long-term Debt0.00
Other liabilities, Noncurrent0.03
Total Liabilities1.82
Stockholders' Equity
Other Equity62.85
Common Stockholder's Equity62.85
Total Stockholder's Equity62.85
Liabilities & Stockholder's Equity64.67
4 historic quarters locked

Sign in to unlock the full Bright Minds Biosciences Inc balance sheet history.

Sign In Create Free Account

About Bright Minds Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 40-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-25-038729

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.